Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Blood Cells, Molecules & Diseases|November 1, 2011
The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell linesCarlo Visco, Silvia Castegnaro, Katia Chieregato, et al.
Journal of Clinical Medicine|October 16, 2024
Visceral Leishmaniasis Following A+AVD Treatment in a Patient with Classical Hodgkin's Lymphoma: A Case Report and Review of the LiteratureDaniela Estefania Banegas, Alessia Moioli, Eleonora Santoni, et al.
American Journal of Hematology|November 22, 2007
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative casesFrancesca Scognamiglio, Chiara Corso, Domenico Madeo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 9, 2015
Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90Federico Riccardi Sirtori, Dannica Caronni, Maristella Colombo, et al.
Hematological Oncology|October 17, 2022
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendationsFrancesco Passamonti, Emanuele Nicastri, Alice Di Rocco, et al.
Haematologica|May 4, 2006
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphomaCarlo Visco, Fabio Canal, Claudia Parolini, et al.
British Journal of Haematology|March 16, 2004
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditionsMauro Krampera, Francesca Venturini, Fabio Benedetti, et al.
American Journal of Hematology|June 22, 2012
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemiaGianluigi Reda, Francesco Maura, Giuseppe Gritti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2026
PET-guided early identification of CAR-T candidates in diffuse large b-cell lymphoma: a multidisciplinary expert consensusLuca Guerra, Domenico Albano, Piera Angelillo, et al.
American Journal of Hematology|March 2, 2013
The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemiaCarlo Visco, Silvia Finotto, Fabrizio Pomponi, et al.
Pageof 17